Alternative mydriasis techniques for retinopathy of prematurity screening
- PMID: 32772218
- DOI: 10.1007/s10792-020-01542-x
Alternative mydriasis techniques for retinopathy of prematurity screening
Abstract
Purpose: There is a large variation in mydriatic regimens used in screening for retinopathy in preterm infants. Except for the standard instillation of mydriatic drops in their commercial formulation, other techniques for pupil dilation have also been described. This study aimed to review all techniques that have been used for mydriasis in retinopathy of prematurity eye examination (ROPEE) screening.
Methods: A comprehensive literature search was performed in PubMed, Cochrane library, Trip database, and Scopus, using the key words: "mydriasis", "techniques", "mydriatics", "dilating drops", "retinopathy of prematurity", "ROP", "phenylephrine", "cyclopentolate", "tropicamide", "smaller mydriatic drops", "reduction in drop size" to February 2019.
Results: Five primary studies were included, assessing the techniques of microdrops, lower conjunctival fornix (LCF) packing and Mydriasert® ophthalmic insert. Reported efficacy was similar to commercial eyedrops instillation. Microdrops appeared to have a superior safety profile. LCF packing and Mydriasert lead to increased blood pressure, without serious complications, necessitating further safety studies.
Conclusions: Of all alternative mydriasis techniques for ROPEE screening that have been described, microdrops appear to be the safest yet still effective technique in the fragile population of premature infants in risk of ROP.
Keywords: Dilation; Mydriasis; Mydriatics; Preterm infants; Retinopathy of prematurity.
Similar articles
-
Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trial.Trials. 2022 Apr 15;23(1):322. doi: 10.1186/s13063-022-06243-7. Trials. 2022. PMID: 35428316 Free PMC article.
-
Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening: The MyMiROPS Randomized Clinical Trial.JAMA Ophthalmol. 2025 Feb 1;143(2):110-116. doi: 10.1001/jamaophthalmol.2024.5462. JAMA Ophthalmol. 2025. PMID: 39724200 Clinical Trial.
-
Efficacy and safety of mydriatic microdrops for retinopathy of prematurity screening: an external pilot crossover randomized controlled trial.J Perinatol. 2022 Mar;42(3):371-377. doi: 10.1038/s41372-021-01229-w. Epub 2021 Oct 15. J Perinatol. 2022. PMID: 34654903 Clinical Trial.
-
Systematic review of mydriatics used for screening of retinopathy in premature infants.BMJ Paediatr Open. 2019 May 9;3(1):e000448. doi: 10.1136/bmjpo-2019-000448. eCollection 2019. BMJ Paediatr Open. 2019. PMID: 31206081 Free PMC article.
-
Mydriatic insert and intracameral injections compared with mydriatic eyedrops in cataract surgery: controlled studies.J Cataract Refract Surg. 2015 Jul;41(7):1503-19. doi: 10.1016/j.jcrs.2014.12.050. J Cataract Refract Surg. 2015. PMID: 26287888 Review.
Cited by
-
Optimizing instilled drug delivery: a scoping review of microdrops in ophthalmology.Graefes Arch Clin Exp Ophthalmol. 2025 Jul;263(7):1765-1787. doi: 10.1007/s00417-025-06773-1. Epub 2025 Feb 26. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 40011238 Free PMC article. Review.
-
Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trial.Trials. 2022 Apr 15;23(1):322. doi: 10.1186/s13063-022-06243-7. Trials. 2022. PMID: 35428316 Free PMC article.
-
Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening: The MyMiROPS Randomized Clinical Trial.JAMA Ophthalmol. 2025 Feb 1;143(2):110-116. doi: 10.1001/jamaophthalmol.2024.5462. JAMA Ophthalmol. 2025. PMID: 39724200 Clinical Trial.
References
-
- Kremer LJ, Reith DM, Medlicott N, Broadbent R (2019) Systematic review of mydriatics used for screening of retinopathy in premature infants. BMJ Paediatr Open 3(1):e000448. https://doi.org/10.1136/bmjpo-2019-000448 - DOI - PubMed - PMC
-
- Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928 - DOI - PubMed - PMC
-
- Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute Web site. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed 20 Aug 2019
-
- Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Son F et al (2003) Evaluating non-randomised intervention studies. Health Technol Assess 7(27):1–173. https://doi.org/10.3310/hta7270 - DOI
-
- Lynch MG, Brown RH, Goode SM, Schoenwald RD, Chien S (1987) Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption. Arch Ophthalmol 105(10):1364–1365. https://doi.org/10.1001/archopht.1987.01060100066027 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials